Clinical trial
PROTECTIVE EFFECT OF SGLT2 INHIBITORS ON POST-CONTRAST MEDIUM INDUCED ACUTE KIDNEY INJURY IN DIABETIC AND CKD PATIENTS
NCT06288529 is registered in ClinicalTrials.gov with University of Health Sciences Balikesir Hospital Eduation and Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PROTECTIVE EFFECT OF SGLT2 INHIBITORS ON POST-CONTRAST MEDIUM INDUCED ACUTE KIDNEY INJURY IN DIABETIC AND CKD PATIENTS
- Lead sponsor
- University of Health Sciences Balikesir Hospital Eduation and Research
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 15, 2023
- Completion date
- January 31, 2024
- Enrollment
- 975 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic kidney diseases, type2diabetes